Health Resources and Services Administration
Ryan White HIV/AIDS Program Part F Dental Reimbursement Program
About This Grant
The purpose of the Ryan White HIV/AIDS Program (RWHAP) Part F Dental Reimbursement Program (DRP) is to improve access to oral health care services for low-income people with HIV, and related education and training to dental providers serving people with HIV. Authorized under section 2692(b) of the Public Health Service Act (42 U.S.C. § 300ff–111(b)), the DRP provides partial reimbursement to eligible dental schools and accredited dental hygiene programs for the unreimbursed costs of oral health care provided to patients with HIV. Eligible institutions may annually apply for reimbursement based on costs incurred in the prior year. Available funds are distributed among all eligible applicants, taking into account the number of patients with HIV served and the extent of unreimbursed care costs relative to other applicants.
Who Can Apply
Focus Areas
Additional Details
- CFDA / ALN Number
- 93.924
- Program Title
- Ryan White HIV/AIDS Dental Reimbursement and Community Based Dental Partnership Grants
- Expected Awards
- 50
- Estimated Total Funding
- Up to $9M
- Source
- Grants.gov · View original listing
Similar Grants
Center for Medicare and Medicaid Services
Make America Healthy Again – Enhancing Lifestyle and Evaluating Value-based Approaches Through Evidence
Up to $3.3MDue in 7 days — May 15, 2026Centers for Disease Control and Prevention - ERA
Occupational Safety and Health Education and Research Centers (T42)
$4.5M – $9MDue October 26, 2028National Institutes of Health
Risk and Protective Factors of Family Health and Family Level Interventions (R01 Clinical Trial Optional)
Due May 8, 2027National Institutes of Health
Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed)
Due June 1, 2027National Institutes of Health
Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
Due November 18, 2026National Institutes of Health
Focused Technology Research and Development (R01 Clinical Trial Not Allowed)
Due January 7, 2028